AU9071098A - Breast cancer resistance genes, methods for their detection and uses thereof - Google Patents

Breast cancer resistance genes, methods for their detection and uses thereof

Info

Publication number
AU9071098A
AU9071098A AU90710/98A AU9071098A AU9071098A AU 9071098 A AU9071098 A AU 9071098A AU 90710/98 A AU90710/98 A AU 90710/98A AU 9071098 A AU9071098 A AU 9071098A AU 9071098 A AU9071098 A AU 9071098A
Authority
AU
Australia
Prior art keywords
detection
methods
breast cancer
resistance genes
cancer resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90710/98A
Inventor
Lambert C. J. Dorssers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU9071098A publication Critical patent/AU9071098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU90710/98A 1997-07-29 1998-07-29 Breast cancer resistance genes, methods for their detection and uses thereof Abandoned AU9071098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5410197P 1997-07-29 1997-07-29
US60054101 1997-07-29
PCT/EP1998/004754 WO1999006831A2 (en) 1997-07-29 1998-07-29 Breast cancer resistance genes, methods for their detection and uses thereof

Publications (1)

Publication Number Publication Date
AU9071098A true AU9071098A (en) 1999-02-22

Family

ID=21988820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90710/98A Abandoned AU9071098A (en) 1997-07-29 1998-07-29 Breast cancer resistance genes, methods for their detection and uses thereof

Country Status (2)

Country Link
AU (1) AU9071098A (en)
WO (1) WO1999006831A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU741133B2 (en) * 1998-04-23 2001-11-22 Genentech Inc. SH2 domain-containing peptides

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO972006D0 (en) 1997-04-30 1997-04-30 Forskningsparken I Aas As New method for diagnosis of diseases
US6891022B1 (en) 1998-04-23 2005-05-10 Genentech, Inc. NSP molecules
GB0412301D0 (en) 2004-06-02 2004-07-07 Diagenic As Product and method
FR2881830B1 (en) * 2005-02-09 2007-05-04 Ct De Rech Pour Les Pathologie PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROSTATE CANCER
WO2007073774A1 (en) * 2005-12-23 2007-07-05 Universita' Degli Studi Di Torino Genotoxic testing
WO2010009171A2 (en) * 2008-07-14 2010-01-21 Wyeth Src activation for determining cancer prognosis and as a target for cancer therapy
EP2669682B1 (en) 2012-05-31 2017-04-19 Heinrich-Heine-Universität Düsseldorf Novel prognostic and predictive biomarkers (tumor markers) for human breast cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5119827A (en) * 1990-09-05 1992-06-09 Board Of Regents, The University Of Texas System Mechanisms of antiestrogen resistance in breast cancer
US5292638A (en) * 1990-12-07 1994-03-08 The Regents Of The University Of California Method of determining functional estrogen receptors for prognosis of cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU741133B2 (en) * 1998-04-23 2001-11-22 Genentech Inc. SH2 domain-containing peptides

Also Published As

Publication number Publication date
WO1999006831A9 (en) 1999-07-29
WO1999006831A3 (en) 1999-09-02
WO1999006831A2 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
AU4095999A (en) Cell cycle genes, proteins and uses thereof
AU3931300A (en) Methods for identifying pathway-specific reporters and target genes, and uses thereof
AU5054198A (en) Biospecific, two photon excitation, fluorescence detection and device
AU6059699A (en) Synthetic peptides, conjugation reagents and methods
AU1344400A (en) Inflammation-associated genes
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU5691699A (en) Human genes differentially expressed in colorectal cancer
AU6257298A (en) Breast cancer specific gene 1
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU1687697A (en) Cancer detection probes
HUP0104825A3 (en) Genes and proteins, and their use
AU4528696A (en) Cancer detection probes
AU9071098A (en) Breast cancer resistance genes, methods for their detection and uses thereof
AU5340699A (en) Human anion transporter genes atnov
AU6417799A (en) Matrix-remodeling genes
AU1138699A (en) Dna demethylase, therapeutic and diagnostic uses thereof
AU8919098A (en) Fumonosin resistance
AP2006003504A0 (en) Outer surface proteins, their genes, and their use.
AU4860299A (en) (zap-3) tumor associated genes and their uses
AU1457300A (en) Dna replication-regulating genes, antibodies thereto and diagnostic applicationsthereof
AU2750197A (en) Dna replication-regulating genes
AU3524500A (en) (rab) genes and their uses
AU7804300A (en) Modified resistance genes
AU5632500A (en) Cancer associated antigens and uses therefor
AU6780998A (en) Human tumorigenesis associated protein, htap

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase